|
Barón-Esquivias G, Marín F, Sanmartín Fernandez M. Rivaroxaban in patients with atrial fibrillation: from ROCKET AF to everyday practice. Expert Rev Cardiovasc Ther. 2017 May;15(5):403-413. doi: 10.1080/14779072.2017.1309293. Epub 2017 Mar 28. Review. PubMed PMID: 28319424.
AÑO: 2017
|
28319424
|
de Isla L.P., Fernández P.L.S., Walther L.Á.S., Alonso V.B., Conde A.C., Basilio E.G., Ortiz L.G., López P.M., Ezquerra E.A., Fort A.C., Sales J.C., Cervantes C.E., Marimón X.G.M., Doblas J.J.G., Martín D.M., Eizagaechevarria N.M., de Pablo Zarzosa C., Rincón L.M., Forés J.S., Calvar J.A.S.R., Manterola F.A., Ynsaurriaga F.A., Masip A.E., González I.F., Navarro M.J., Ortuño F.M., Padial L.R., Fernández P.L.S., Green A.S., García R.V. Comments on the 2016 ESC/EAS Guidelines for the Management of Dyslipidemias. Revista Espanola de Cardiologia. 1 February 2017. 70:72-77. 10.1016/j.recesp.2016.11.051
AÑO: 2017; IF: 5.166
|
|
Esteve-Pastor MA, García-Fernández A, Roldán V, Marín F. Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants. Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):132-133. doi: 10.1016/j.rec.2016.11.006. Epub 2016 Dec 27. English, Spanish. PubMed PMID: 28034682.
AÑO: 2017; IF: 5.166
|
|
Esteve-Pastor MA, Rivera-Caravaca JM, Shantsila A, Roldán V, Lip GYH, Marín F. Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial. Thromb Haemost. 2017 Dec;117(12):2261-2266. doi: 10.1160/TH17-10-0710. Epub 2017 Dec 6. PubMed PMID: 29212113.
AÑO: 2017; IF: 4.952
|
|
Lip G.Y.H., Collet J.P., Caterina R.D., Fauchier L., Lane D.A., Larsen T.B., Marin F., Morais J., Narasimhan C., Olshansky B., Pierard L., Potpara T., Sarrafzadegan N., Sliwa K., Varela G., Vilahur G., Weiss T., Boriani G., Rocca B., Gorenek B., Savelieva I., Sticherling C., Kudaiberdieva G., Chao T.F., Violi F., Nair M., Zimerman L., Piccini J., Storey R., Halvorsen S., Gorog D., Rubboli A., Chin A., Scott-Millar R. Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Europace. 1 November 2017. 19:1757-1758. 10.1093/europace/eux240
AÑO: 2017; IF: 5.231
|